The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis

Completed

Conditions studied: Allergic Asthma, Allergic Rhinitis

In brief

This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.

Key facts

Study ID

NCT01318954

Run by

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

People needed

17

Starts

2008-01-01

Expected to finish

2011-06-01

Last updated by the study team

2015-10-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects over 18 years old with allergic asthma and/or allergic rhinitis who are beginning allergen desensitization

You may not qualify if…

• Smokers
• Subjects of dimished capacity

Where it is running

• Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. — Bryn Mawr, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.